GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

efanesoctocog alfa   Click here for help

GtoPdb Ligand ID: 13086

Synonyms: ALTUVIIIO® | Altuvoct® | BIVV-001 | BIVV001 | Fc-VWF-XTEN
Approved drug
efanesoctocog alfa is an approved drug (FDA (2023), EMA (2024))
Compound class: Peptide
Comment: Efanesoctocog alfa (BIVV-001) is a recombinant protein that fuses factor VIII (FVIII) to a human IgG1 Fc domain. It was designed as a long-acting FVIII replacement therapy [4]. Pharmacodynamic effects of efanesoctocog alfa (clot formation) are identical to those elicited by recombinant FVIII [1].
Classification Click here for help
Compound class Peptide
Approved drug? Yes. US FDA (2023)
International Nonproprietary Names Click here for help
INN number INN
11314 efanesoctocog alfa
Synonyms Click here for help
ALTUVIIIO® | Altuvoct® | BIVV-001 | BIVV001 | Fc-VWF-XTEN
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 701
Other databases
GtoPdb PubChem SID 491299868
Search PubMed clinical trials efanesoctocog alfa
Search PubMed titles efanesoctocog alfa
Search PubMed titles/abstracts efanesoctocog alfa